Journal article
Modulating nasal mucosal permeation using metabolic saturation and enzyme inhibition techniques
Journal of pharmacy and pharmacology, Vol.69(9), pp.1075-1083
08/01/2017
DOI: 10.1111/jphp.12749
PMID: 28542812
Abstract
Abstract Objective Presystemic elimination resulting from local enzymatic degradation can play a key role in limiting the bioavailability of intranasally administered drugs. The aim of this study was to evaluate the transfer of a metabolically susceptible drug across the nasal mucosa to illustrate the relative contributions of drug diffusivity and metabolic susceptibility on overall nasal mucosal permeation and to understand the effects of changes in enzymatic activity on the transfer across nasal epithelial and submucosal tissues. Methods The concentration-dependent permeation of melatonin, a CYP450 substrate, across excised bovine nasal olfactory and respiratory explants was studied along with quantifying the extent of melatonin 6-hydroxylation. Microsomal preparations were also used to determine the kinetic parameters for melatonin to 6-hydroxymelatonin biotransformation. Key findings Enzyme saturation at higher melatonin concentrations and inclusion of a CYP450 inhibitor both resulted in the significant increase in melatonin permeation across the nasal mucosa. Conclusions Metabolic loss of melatonin during nasal permeation demonstrates CYP450 activity in the nasal epithelium and submucosal tissues. The extent of biotransformation of melatonin during its transport across the nasal mucosal explants suggests that, although the nasal route bypasses hepatic first-pass metabolism, nasal bioavailability can be significantly influenced by mucosal enzymatic activity.
Details
- Title: Subtitle
- Modulating nasal mucosal permeation using metabolic saturation and enzyme inhibition techniques
- Creators
- Varsha Dhamankar - Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USAMaureen D Donovan - Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA
- Resource Type
- Journal article
- Publication Details
- Journal of pharmacy and pharmacology, Vol.69(9), pp.1075-1083
- DOI
- 10.1111/jphp.12749
- PMID
- 28542812
- ISSN
- 0022-3573
- eISSN
- 2042-7158
- Language
- English
- Date published
- 08/01/2017
- Academic Unit
- Pharmaceutical Sciences and Experimental Therapeutics
- Record Identifier
- 9984065692302771
Metrics
10 Record Views